Parkinsonism and the use of Tranquilizers

Ayd F.J. : (a) The Physiologic and Neurologic Action of Chlorpromazine. Psychiat. Res. Rep. Amer. Psychiat. Ass. 1:14, 1955. (b) Current Status of the Phenothiazine Tranquilizers. Tran. Fifth Meeting Acad. Psychosomatic Med. p. 217, 1958.

Azima H. , Durost H. , and Arthurs D. : The Effect of Thioridazine (Mellaril) on Mental Syndromes Comparison with Chlorpromazine and Promazine. Canad. Med. Ass. J. 81: 549, 1959.

Basmajian J. V. , and Szatmari A. : Effect of Largactil (Chlorpromazine) on Human Spasticity and Electromyogram. A.M.A. Arch. Neurol. & Psychiat. 73: 224, 1955.

Bird E. G. , Goss J. D. , and Denber H. C. : Chlorpromazine in the Treatment of Mental Illness. Amer. J. Psychiat. 111: 930, 1955.

Blockus L. E. , and Everett G. M. : Fed. Proc. 16: 283, 1957.

Bovet D. , and Longo V. G. : The Action on Nicotine-induced Tremors of Substances Effective in Parkinsonism. J. Pharmacol. Exp. Ther. 102: 22, 1951.

Boyd E. M. : Chlorpromazine Tolerance and Physical Dependence. J. Pharmacol. Exp. Ther. 128: 75, 1960.

Cohen I. M. : Undesirable Effects and Clinical Toxicity of Chlorpromazine. J. Clin. Exp. Psychopath. 17: 153, 1956.

Courvoisier S. , Fournel J. , Ducrot R. , Kolsky M. , and Koetschet P. : Propriétés Pharmacodynamiques Du Chlorhydrate De Chloro-3 (Diméthylamino-3' proply)-10 Phenothiazine (4.560 R.P.). Arch. int. pharmacodyn. 92: 305, 1953.

De Boucaud P. , and Fournial P. : Etats Parkinsoniens Apparus au Cours de Traitement à la Chlorpromazine. J. Med. Bordeaux 131: 881, 1954.

Doshay L. J. : Thirty Years of Progress in Therapy for Paralysis Agitans (Parkinson's Disease). J.A.M.A. 167: 1195, 1958.

Duff R. S. : Use of Diparcol in Parkinsonism. Brit. Med. J. 1: 613, 1949.

Everett G. M. , Blockus L. E. , Shepperd I. M. , and Toman J. E. P. : Production of Tremor and a Parkinson-like syndrome by l-4-Dipyrrolidino-2-butyne, “Tremorine”. Fed. Proc. 15: 420, 1956.

Freed H. , and Peifer C. A. : Some Considerations on the Use of Chlorpromazine in a Child Psychiatry Clinic. J. Clin. Exp. Psychopath. 17: 164, 1956.

Freyhan F. A. : Psychomotility and Parkinsonism in Treatment with Neuroleptic Drugs. A.MA. Arch. Neurol. & Psychiat. 78: 465, 1957.

Freyhan F. A. : Extrapyramidal Symptoms and Other Side Effects in Trifluoperazine p. 195, Lea & Febiger, Philadelphia, 1958.

Garai O. : Lysivane and Artane in the Treatment of Parkinsonism. Lancet. 260: 429, 1951.

Gillhespy R. O. : “Lysivane” in the Treatment of Parkinsonism. Brit. Med. J. 2:201, 1951.

Goldman D. : The Results of Treatment of Psychotic States with Newer Phenothiazine Compounds Effective in Small Doses. Amer. J. Med. Sci. 235: 67, 1958.

Gowdey C. W. , McKay A. R. , and Torney D. : Effects of Levomepromazine and Chlorpromazine on Conditioning and Other Responses of the Nervous System. Arch. int. pharmacodyn. 123: 352, 1960.

Himwich H. E. , Rinaldi F. , and Willis D. : An Examination of Phenothiazine Derivatives with Comparisons of their Effects on the Alerting Reaction, Chemical Structure and Therapeutic Efficacy. J. Nerv. Ment. Ds. 124: 53, 1956.

Irwin S. : Comparative Potency of Phenothiazine Tranquilizers in Suppressing Avoidance and Locomotor Behavior: Its Implication. The Pharmacologist. 1: 51, 1959.

Kinross-Wright V. : Complications of Chlorpromazine Treatment. Dis. Nerv. Syst. 16: 114, 1955.

Kinross-Wright V. : Chlorpromazine in Psychiatric Disorders. Med. Clin. N. Amer. p. 295, 1957.

Kinross-Wright V. J. : New Horizons in the Chemotherapy of Mental Disease. S. Afr. Med. J. 31: 1167, 1957.

Kinross-Wright J. : Newer Phenothiazine Drugs in Treatment of Nervous Disorders. J.A.M.A. 170: 1283, 1959.

Konehegul L. : The Use of Kemadrin in the Treatment of Drug-Induced Parkinsonism. Med. Ann. D.C. 27: 405, 1958.

Lehmann H. E. : (a) Therapeutic Results with Chlorpromazine (Largactil) in Psychiatric Conditions. Canad. Med. Ass. J. 72:91, 1955. (b) Neurophysiologic Activity of Chlorpromazine in Clinical Use. J. Clin. Exp. Psychopath. 17:129, 1956.

Macchi G. , Manghi E. , and Saginario M. : Riv. sper. Freniat. 78: 1, 1954. quoted from Lehmann ref. 28 (a).

Moore R. , Sigg E. B. , and Schneider J. A. : A Simple Method for Recording Tremors in Mice. J. Appl. Psysiol. 11: 488, 1957.

Moyer J. H. , Pevey K. , and Kinross-Wright V. : Tranquilizing (Ataractic) Agents: Current Evaluation of their Clinical Use in Patients who are not Hospitalized. GP 15: 97, 1957.

Montuschi E. , Phillips J. , Prescott F. , and Green A. F. : Kemadrin in Postencephalitic Parkinsonism. Lancet 262: 583, 1952.

Palmer H. , and Gallagher D. J. A. : Lysivane Therapy for Parkinsonism. Brit. Med. J. 2: 558, 1950.

Rinaldi F. , and Himwich H. E. : Drugs Affecting Psychotic Behavior and the Function of the Mesodiencephalic Activating System. Dis. Nerv. Syst. 16: 133, 1955.

Rupp G. , Leopold R. L. , and King G. : 1. Neurology in Proc. Neurol. & Psychiat. XI. p. 26, Grune & Stratton, New York, 1956.

Schlesinger E. B. : The Clinical Pharmacology of Diparcol. Trans. Amer. Neurol. Ass. p. 233, 1949.

Schwab R. A. , and Chafetz M. E. : Kemadrin in the Treatment of Parkinsonism. Neurology 5: 273, 1955.

Schwab R. S. , and England A. C. : Newer Preparations in the Treatment of Parkinsonism. Med. Clin. N. Amer. p. 369, 1957.

Sigwald J. , Bovet D. , and Dumont G. : Le traitement de la maladie de Parkinson par le chlorhydrate de diéthylaminoéthyl-N-thiodiphénylamine (2987 R.P.). Rev. Neurol. (Paris) 78: 581, 1946.

Sigwald J. : Un Nouveau Médicament Symptomatique Des Syndromes Parkinsoniens. Presse Méd. 57: 819, 1949.

Spector W. S. : editor Handbook of Biological Data. p. 366, W. B. Saunders, Philadelphia, 1956.

Tedeschi D. H. , Spencer J. N. , Macko E. , Tedeschi R. E. , Leonard C. A. , McLean R. A. , Flanagan T. , Cook L. , Mattis P. A. , and Fellows E. J. : in Trifluoperazine 1. Psychopharmacology, Pharmacology and Chemistry, p. 23, Lea Febiger, Philadelphia, 1958.

Timberlake W. H. , and Schwab R. S. : Experimental Preparation W-483 in the Treatment of Parkinson's Disease. New Engl. J. Med. 247: 98, 1952.

Zier A. , and Doshay L. J. : Procyclidine Hydrochloride (Kemadrin) Treatment of Parkinsonism. Neurology 7: 485, 1957.